Skip to main content

stock

KTTAW · Pasithea Therapeutics Corp.

What Pasithea Therapeutics Corp. reports to the SEC, read from its filings.

Open in the app

Price

The live KTTAW price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on KTTAW.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
33,414,448 as of 2026-08-12 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-42.7%
ROA
-41.2%

Health

Current ratio
26.2x
Debt/equity
—

Deep value

NCAV
$46.37M
NCAV per share
$1.39
Price/NCAV
Locked
NNWC
$43.79M
NNWC per share
$1.31
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30——-$5.71M-$5.27M
10-Q filed 2026-08-14
2026-03-31——-$4.88M-$2.87M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31——-$10.26M-$10.11M
10-K filed 2026-03-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30——-$3.11M-$3.04M
10-Q filed 2025-11-13
2025-06-30——-$3.81M-$3.72M
10-Q filed 2026-08-14
2025-03-31——-$3.68M-$3.56M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31——-$3.26M-$3.18M
10-K filed 2026-03-30
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30——-$3.00M-$3.00M
10-Q filed 2025-11-13
Assets
$51.71M
Equity
$49.84M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$20.86M-$20.43M—
2024-12-31—-$14.25M-$13.90M—
2023-12-31—-$15.98M-$15.96M—
2022-12-31$486,559-$12.59M-$13.94M-$14.67M
2021-12-31$15,062-$4.51M-$2.17M-$3.20M

Company filings

1 offering filing in 12 months

events

  • Other event

    Other event
    Sep 168-K
  • Shareholder vote results

    Shareholder vote results
    Sep 98-K
  • Listing standard notice

    Listing standard notice
    Aug 218-K
  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    May 48-K
  • Listing standard notice

    Listing standard notice
    Feb 208-K
  • Executive or director change, Bylaws or fiscal year change, Shareholder vote results

    Executive or director changeBylaws or fiscal year changeShareholder vote results
    Jan 288-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named KTTAW, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about KTTAW.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about KTTAW.

nakagai

Signals on KTTAW come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the KTTAW board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Pasithea Therapeutics Corp. (KTTAW): SEC filings, financials and insider trades · Nakagai